“…In addition to the aforementioned compounds, which represent the most studied Nrf2 activators with neuroprotective effects in experimental models of ischemic stroke, additional drugs (less frequently investigated compounds) have also shown beneficial effects, such as tanshinol borneol ester [ 270 ], Apelin 13 [ 141 ], ezetimibe [ 271 ], rosmarinic acid [ 100 ], biochanin A [ 272 ], isoquercetin [ 273 ], trilabatin [ 137 ], forsythiaside A [ 274 ], octreotide [ 275 ], Korean Red Ginseng [ 89 ], Schizandrin A [ 276 ], leonurine [ 277 ], sinomenine [ 101 ], myricetin [ 139 ], diterpene ginkgolides [ 278 ], totarol [ 279 ], paeonol [ 91 ], alpha-lipoic acid [ 280 ], omega-3 fatty acids [ 281 ], nicotinamide mononucleotide [ 282 ], chlorogenic acid [ 144 ], eriocitrin [ 283 ], bicyclol [ 114 ] andrographolide [ 284 ], phyllanthin [ 285 ], neohesperidin [ 286 ], protocatechualdehyde [ 287 ], osthole [ 275 ], salidroside [ 288 ], palmatine [ 289 ], pelargonidin [ 290 ] and britanin [ 291 ].…”